Evaluation of a microfluidic chip‐based cell sorter in clinical manufacturing processes to deplete or isolate CD4 regulatory T cells

Documenti analoghi

• Healthcare center‐based cell therapy laboratories supporting off‐site manufactured cell therapies: The experiences of a single academic cell therapy laboratory
  di: Anh Dinh, et al.
  Pubblicazione: (2024)
• Prediction of CD34+ hematopoietic stem cells in healthy allogeneic stem cell donors on the Optia cell separator based on CE2: Which formula is more correlated with actual CD34+?
  di: Sıdıka Gülkan Özkan, et al.
  Pubblicazione: (2024)
• Method comparison between hematopoietic progenitor cell and CD34+ cell counts in hematopoietic stem cell collection
  di: Thibault Lavalleye, et al.
  Pubblicazione: (2024)
• Multi‐center development and validation of a standardized protocol for biotinylated red blood cell analysis
  di: Susanne Marschner, et al.
  Pubblicazione: (2026)
• Patient characteristics and clinical determinants of outpatient red cell transfusions
  di: Nora Hemesath, et al.
  Pubblicazione: (2025)